Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
  1. 2018
  2. Published

    Serum uric acid and progression of diabetic nephropathy in type 1 diabetes

    Pilemann-Lyberg, S., Lindhardt, M., Persson, F., Andersen, S. & Rossing, P., 1 May 2018, In: Journal of Diabetes and its Complications. 32, 5, p. 470-473 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. 2016
  4. Published

    Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

    Pena, M. J., Heinzel, A., Rossing, P., Parving, H-H., Dallmann, G., Rossing, K., Andersen, S., Mayer, B. & Heerspink, H. J. L., 5 Jul 2016, In: Journal of Translational Medicine. 14, 1, p. 203

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 2015
  6. Published
  7. Published
  8. Published

    Effect of Continuous Glucose Monitoring Accuracy on Clinicians' Retrospective Decision Making in Diabetes: A Pilot Study

    Mahmoudi, Z., Johansen, M. D., Nørgaard, H. H., Andersen, S., Pedersen-Bjergaard, U., Tarnow, L., Christiansen, J. S. & Hejlesen, O., 8 Jun 2015, In: Journal of diabetes science and technology. 9, 5, p. 1092-1102

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. 2014
  10. Published

    Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness

    Vestergaard Rosenlund, S., Theilade, S., Hansen, T. W., Andersen, S. & Rossing, P., Dec 2014, In: Acta Diabetologica. 51, 6, p. 955-62 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. 2007
  12. Published

    CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy

    Lajer, M., Tarnow, L., Andersen, S. & Parving, H-H., Mar 2007, In: Diabetic Medicine. 24, 3, p. 323-5 3 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. 2006
  14. Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy

    Nguyen, T. Q., Tarnow, L., Andersen, S., Hovind, P., Parving, H-H., Goldschmeding, R. & van Nieuwenhoven, F. A., Jan 2006, In: Diabetes Care. 29, 1, p. 83-8 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy

    Schjoedt, K. J., Lajer, M., Andersen, S., Tarnow, L., Rossing, P. & Parving, H-H., 2006, In: Scandinavian Journal of Clinical and Laboratory Investigation. 66, 3, p. 173-80 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. 2005
  17. Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy

    Andersen, S., van Nieuwenhoven, F. A., Tarnow, L., Rossing, P., Rossing, K., Wieten, L., Goldschmeding, R. & Parving, H-H., Jun 2005, In: Kidney International. 67, 6, p. 2325-9 5 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Renoprotection with and without blood pressure reduction

    Laverman, G. D., Andersen, S., Rossing, P., Navis, G., de Zeeuw, D. & Parving, H-H., Apr 2005, In: Kidney International, Supplement. 94, p. S54-9

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. 2004
  20. Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points

    Parving, H-H., Andersen, S., Jacobsen, P., Christensen, P. K., Rossing, K., Hovind, P., Rossing, P. & Tarnow, L., 2004, In: Seminars in Nephrology. 24, 2, p. 147-57 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. 2003
  22. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen, S., Tarnow, L., Cambien, F., Rossing, P., Juhl, T. R., Deinum, J. & Parving, H-H., 2003, In: Diabetes Care. 26, 5, p. 1501-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. 2002
  24. Published
  25. Published
  26. Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

    Andersen, S., Tarnow, L., Cambien, F., Rossing, P., Juhl, T. R., Deinum, J. & Parving, H-H., 2002, In: Kidney International. 62, 1, p. 192-8 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. 2000
  28. Published

    Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy

    Bos, H., Andersen, S., Rossing, P., De Zeeuw, D., Parving, H. H., De Jong, P. E. & Navis, G., Apr 2000, In: Kidney International, Supplement. 75, p. S32-7

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

    Andersen, S., Tarnow, L., Rossing, P., Hansen, B. V. & Parving, H. H., Feb 2000, In: Kidney International. 57, 2, p. 601-6 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 44814553